The Efficacy of Low - Dose Intravenous Tranexamic Acid in Reducing Postoperative Blood Loss in Arthroscopic Anterior Cruciate Ligament Reconstruction

Authors

  • Thanatja Kittijarukajon Chonburi Hospital
  • Kantanop Thitirungruang Chonburi Hospital
  • Saroj Saruchwongkraivete Chonburi Hospital
  • sanyakupta boonperm Chonburi hospital

Abstract

Purpose: This prospective, randomized, double-blind study aimed to assess the efficacy of single intravenous administration of low-dose tranexamic acid (TXA) in arthroscopic anterior cruciate ligament reconstruction (ACLR) for minimizing postoperative blood loss. Secondary objectives included assessing early postoperative pain levels, range of knee flexion, knee joint hemarthrosis, and TXA-associated complications.

Methods: Sixty patients undergoing arthroscopic ACLR were randomly assigned to either the treatment group (n = 30), receiving a single bolus dose of 10 mg/kg TXA intravenously 10 minutes before surgery, or the control group (n = 30), receiving an equal volume of normal saline via the same route. The volume of drained blood was measured at 3 and 24 hours postoperatively. Hemarthrosis grade was assessed in postoperative weeks 1 and 2. Pain levels were evaluated using a visual analog scale (VAS) at postoperative day 1, week 1, and week 2. Knee flexion range was recorded at the end of postoperative week 2 and week 4.

Results: Patient demographics were comparable between the two groups. Postoperative reductions in hemoglobin (TXA group 1.10 ± 0.52, control group 1.80 ± 0.71, p<0.001) and hematocrit (TXA group 3.42 ± 1.74, control group 5.41 ± 2.04, p<0.001) were statistically significant in favor of the TXA group. The mean postoperative VAS scores, range of knee flexion, and hemarthrosis grades were similar between the groups. No postoperative complications were reported.

Conclusion: Single intravenous administration of low-dose TXA effectively reduces postoperative blood loss in arthroscopic anterior cruciate ligament reconstruction (ACLR) surgery. However, this intervention did not demonstrate clinical benefits in terms of pain levels, range of motion, or knee hemarthrosis during the early postoperative period. Additional research may be warranted to explore optimal TXA dosing strategies and its impact on functional outcomes in ACLR patients.

Keywords : Tranexamic acid, arthroscopy, ACL reconstruction, hemarthrosis

Author Biographies

Thanatja Kittijarukajon, Chonburi Hospital

Department of Orthopaedics

Kantanop Thitirungruang, Chonburi Hospital

Department of Orthopaedics

Saroj Saruchwongkraivete, Chonburi Hospital

Department of Orthopaedics

sanyakupta boonperm, Chonburi hospital

Department of Orthopaedics

References

Pabinger I, Fries D, Schöchl H, Streif W, Toller W. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr. 2017;129(9–10):303–16.

Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion. 2005;45(8):1302–7.

Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2012;94(13):1153-9.

Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement. J Bone Joint Surg Am. 2014;96(23):1937–44.

Watts CD, Houdek MT, Sems SA, Cross WW, Pagnano MW. Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. J Orthop Trauma. 2017;31(7):345–51.

Bahl V, Goyal A, Jain V, Joshi D, Chaudhary D. Effect of haemarthrosis on the rehabilitation of anterior cruciate ligament reconstruction- single bundle versus double bundle. J Orthop Surg Res. 2013;8(1):1–6.

Davey MS, Hurley ET, Anil U, Moses A, Thompson K, Alaia M, et al. Pain management strategies after anterior cruciate ligament reconstruction: a systematic review with network meta-analysis. Arthroscopy. 2021;37(4):1290-1300.e6.

Johnson SM, Tsang D, Dansby M, Allen C. New and off-label use of tranexamic acid. AACN Adv Crit Care. 2021;32(3):237–42.

Parker JD, Lim KS, Kieser DC, Woodfield TBF, Hooper GJ. Is tranexamic acid toxic to articular cartilage when administered topically? Bone Jt J. 2018;100B(3):404–12.

Bolam SM, O’Regan-Brown A, Paul Monk A, Musson DS, Cornish J, Munro JT. Toxicity of tranexamic acid (TXA) to intra-articular tissue in orthopaedic surgery: a scoping review. Knee Surg Sports Traumatol Arthrosc. 2021;29(6):1862–71.

Coupens SD, Yates CK. The effect of tourniquet use and hemovac drainage on postoperative hemarthrosis. Arthroscopy. 1991;7(3):278–82.

Akgül T, Büget M, Salduz A, Edipoglu IS, Ekinci M, Küçükay S, et al. Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: a prospective clinical study. Acta Orthop Traumatol Turc. 2016;50(4):429–31.

Small NC. Complications in arthroscopic surgery performed by experienced arthroscopists. Arthroscopy. 1988;4(3):215–21.

Haratian A, Shelby T, Hasan LK, Bolia IK, Weber AE, Petrigliano FA. Utilization of tranexamic acid in surgical orthopaedic practice: indications and current considerations. Orthop Res Rev. 2021;13:187–99.

Karaaslan F, Karaoğlu S, Yurdakul E. Reducing intra-articular hemarthrosis after arthroscopic anterior cruciate ligament reconstruction by the administration of intravenous tranexamic acid. Am J Sports Med. 2015;43(11):2720–6.

Felli L, Revello S, Burastero G, Gatto P, Carletti A, Formica M, et al. Single intravenous administration of tranexamic acid in anterior cruciate ligament reconstruction to reduce postoperative hemarthrosis and increase functional outcomes in the early phase of postoperative rehabilitation: a randomized controlled trial. Arthroscopy. 2019;35(1):149–57.

Johns WL, Walley KC, Hammoud S, Gonzalez TA, Ciccotti MG, Patel NK. Tranexamic acid in anterior cruciate ligament reconstruction: a systematic review and meta-analysis. Am J Sports Med. 2021;49(14):4030–41.

Na Y, Jia Y, Shi Y, Liu W, Han C, Hua Y. Administration of tranexamic acid to reduce intra-articular hemarthrosis in ACL reconstruction: a systematic review. Orthop J Sport Med. 2022;10(1):1–9.

Lee JW, Kim SG, Kim SH, Cho HW, Bae JH. Intra-articular administration of tranexamic acid has no effect in reducing intra-articular hemarthrosis and postoperative pain after primary ACL reconstruction using a quadruple hamstring graft: a randomized controlled trial. Orthop J Sports Med. 2020;8(7):1–7.

Fried JW, Bloom DA, Hurley ET, Baron SL, Popovic J, Campbell KA, et al. Tranexamic acid has no effect on postoperative hemarthrosis or pain control after anterior cruciate ligament reconstruction using bone–patellar tendon–bone autograft: a double-blind, randomized, controlled trial. Arthroscopy. 2021;37(6):1883–9.

Dastrup A, Pottegård A, Hallas J, Overgaard S. Perioperative Tranexamic Acid Treatment and Risk of Cardiovascular Events or Death After Total Hip Arthroplasty A Population-Based Cohort Study from National Danish Databases. J Bone Jt Surg Am. 2018;100A(20):1742–9.

Downloads

Published

2024-08-31 — Updated on 2024-09-10

Versions